Picard Medical Completes Successful IPO, Raises $19.55 Million

An update from Picard Medical, Inc. ( (PMI) ) is now available.

Picard Medical, Inc. announced on September 9, 2025, that it completed its initial public offering (IPO) of 4,250,000 shares at $4.00 per share, raising $17 million. The underwriters exercised their over-allotment option, adding 637,500 shares and increasing the gross proceeds to approximately $19.55 million. This IPO marks a significant financial milestone for Picard Medical, enhancing its market presence and potentially impacting its operations and stakeholders positively.

More about Picard Medical, Inc.

Picard Medical, Inc. is the parent company of SynCardia Systems, LLC, based in Tucson, Arizona. SynCardia is a leader in the medical industry, offering the only commercially available total artificial heart technology for patients with end-stage heart failure. The company develops, manufactures, and commercializes the SynCardia Total Artificial Heart, an implantable system that replaces the full functions of a failing or failed human heart. It is the first artificial heart approved by both the FDA and Health Canada and remains the only commercially available artificial heart in the United States and Canada.

Average Trading Volume: 3,452,435

For a thorough assessment of PMI stock, go to TipRanks’ Stock Analysis page.